IBM Digs Deeper Roots In Medtech, As AdvaMed Builds Digital Footprint
Executive Summary
IBM is getting more heavily invested in the medical device industry, announcing two major partnerships this week with diagnostic-maker Illumina and US FDA. The move is part of a larger industry trend of tech firms becoming more active in the medtech sector, and AdvaMed is adjusting to the new context.